|
|
| | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- Basic information |
| Product Name: | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- | | Synonyms: | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)-;(S)-1-((S)-3-(4-bromothiazol-2-yl)-2-((1S,2S)-2-methylcyclopropane-1-carboxamido)propanoyl)Hexahydropyridazine-3-carboxylate;Methyl (S)-1-((S)-3-(4-bromothiazol-2-yl)-2-((1S,2S)-2-methylcyclopropane-1-carboxamido)propanoyl)Hexahydropyridazine-3-carboxylate;RMC-6236 Impurity 2;Methyl (S)-1-[(S)-3-(4-bromothiazol-2-yl)-2-[[(1S,2S)-2-methylcyclopropanecarbonyl]amino]propanoyl]hexahydropyridazine-3-carboxylate;RMC-6236/Daraxonrasib intermediate | | CAS: | 3060084-27-4 | | MF: | C17H23BrN4O4S | | MW: | 459.36 | | EINECS: | | | Product Categories: | | | Mol File: | 3060084-27-4.mol | ![3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- Structure](CAS/20240320/GIF/3060084-27-4.gif) |
| | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- Chemical Properties |
| density | 1.496±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 14.241±0.40(predicted) |
| | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- Usage And Synthesis |
| | 3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[[(1S,2S)-2-methylcyclopropyl]carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)- Preparation Products And Raw materials |
|